CHARACTERISTICS OF PLASMA MAGNESIUM CONCENTRATIONS IN PATIENTS WITH END-STAGE KIDNEY DISEASE TREATED AT MILITARY HOSPITAL 103
Main Article Content
Abstract
Objective: To investigate plasma magnesium (Mg) concentrations in patients with end-stage chronic kidney disease (ECKD) and their relationship with selected anthropometric and biochemical parameters. Methods: A cross-sectional descriptive study with a control comparison was conducted at Military Hospital 103, Military Academy from 2024 to 2025. The study included three groups: control group (n = 50), pre-dialysis group (ECKD patients admitted for preparation for dialysis, not yet on dialysis; n = 20), and dialysis group (ECKD patients undergoing dialysis; n = 100). Results: There was a difference in the distribution of plasma Mg status (high, low, normal) among the study groups. Hypomagnesemia was more common in the pre-dialysis group (20.0%) and the dialysis group (13.0%) compared with the control group (6.0%), while the highest rate of hypermagnesemia was observed in the dialysis group (22.0%) (p = 0.007). In the ECKD dialysis group, plasma Mg concentrations were higher in females than in males (p = 0.019). No associations were found between plasma Mg and age, BMI, or biochemical indices including urea, creatinine, uric acid, albumin, and total plasma protein. Conclusions: The study demonstrated differences in the distribution of plasma Mg status (high, low, normal) between the groups. Among ECKD patients on dialysis, females had higher plasma Mg concentrations than males.
Article Details
Keywords
Plasma magnesium; magnesium; hemodialysis; chronic kidney disease; end-stage kidney disease.
References
2. Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nature Reviews Nephrology. 2024;20(7):473-85.
3. van de Wal-Visscher ER, Kooman JP, van der Sande FM. Magnesium in Chronic Kidney Disease: Should We Care? Blood Purif. 2018;45(1-3):173-8.
4. Zhan Y, Zhang R, Li G. Effect of magnesium on vascular calcification in chronic kidney disease patients: a systematic review and meta-analysis. Ren Fail. 2023;45(1):2182603.
5. Rodelo-Haad C, Pendón-Ruiz de Mier MV, Díaz-Tocados JM, Martin-Malo A, Santamaria R, Muñoz-Castañeda JR, et al. The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities. Frontiers in Cell and Developmental Biology. 2020;Volume 8 - 2020.
6. Leenders NHJ, Vermeulen EA, van Ballegooijen AJ, Hoekstra T, de Vries R, Beulens JW, et al. The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis. Clinical Nutrition. 2021;40(5):3133-47.
7. Cai K, Luo Q, Dai Z, Zhu B, Fei J, Xue C, et al. Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients. PLOS ONE. 2016;11(3):e0152488.
8. Macías Ruiz MdC, Cuenca Bermejo L, Veronese N, Fernández Villalba E, González Cuello AM, Kublickiene K, et al. Magnesium in Kidney Function and Disease—Implications for Aging and Sex—A Narrative Review. Nutrients. 2023;15(7):1710.